President Biden’s proposal for a $35 price cap on insulin has emerged as a crucial campaign issue, aiming to address the soaring costs of the life-saving medication. However, experts suggest that implementing such a cap may not be straightforward due to various factors influencing drug pricing. The proposal underscores the urgent need to address affordability issues surrounding insulin and highlights the complexity of healthcare policy.
Biden Proposes $35 Price Cap for Insulin, Highlighting Pivotal Campaign Issue
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/04/23114238/ezgif.com-webp-to-jpg-converter-88-860x645.jpg)